International Assets Investment Management’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311 Hold
90
– – ﹤0.01% 2296
2026
Q1
$398 Hold
90
– – ﹤0.01% 2148
2025
Q4
$248 Buy
+90
New +$257 ﹤0.01% 2151
2024
Q4
– Sell
-90
Closed -$1.2K – 982
2024
Q3
$1.2K Hold
90
– – ﹤0.01% 1730
2024
Q2
$897 Buy
+90
New +$1.3K ﹤0.01% 2112
2021
Q2
– Sell
-90
Closed – – 704
2021
Q1
$0 Hold
90
– – ﹤0.01% 2180
2020
Q4
$0 Buy
+90
New +$398 ﹤0.01% 2078

Other funds holding CATX

International Assets Investment Management's CATX Position: Q2 2026 in Review

International Assets Investment Management held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 90 shares worth $311. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

International Assets Investment Management first reported a position in CATX in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.2K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • International Assets Investment Management held 90 shares of Perspective Therapeutics worth $311 as of Q2 2026.
  • International Assets Investment Management left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2296 holding.
  • International Assets Investment Management first reported a position in Perspective Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • International Assets Investment Management's Perspective Therapeutics position peaked at $1.2K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.